Cardiovascular risk screening in childhood — formative SAQs · Paeds SAQs

Prompt

Cardiovascular risk screening in childhood

SAQ 1 (10 marks)

An asymptomatic 9-year-old has office BP 124/78 using an unknown cuff size. BMI is elevated. Father had MI at 44. [1] [3]

Outline your immediate BP assessment steps. (3) [1]
What cardiovascular history and examination details matter most? (3) [1] [3]
How will you approach lipids given guideline controversy? (4) [2] [3]

Model answer

Re-measure after rest with correct cuff size; repeat abnormal readings; stage with paediatric guidance rather than adult cut-offs; plot BMI. [1]

History: premature ASCVD/FH family history, kidney/heart disease, drugs, sleep, diet, activity, smoke/vape. Exam: pulses/femorals, heart, thyroid, acanthosis, oedema. [1] [3]

Name USPSTF insufficient evidence for routine asymptomatic screening while recognising premature parental CVD as a strong selective indication; confirm abnormal lipids; consider FH pathway. [2] [3] [6]

SAQ 2 (10 marks)

A child with CKD is reviewed in clinic for cardiovascular risk. [4]

Why is average well-child screening intensity inadequate here? (3) [4]
List first-line preventive actions you can start in general paediatrics. (4) [1] [4] [5]
Safety-net and referral principles. (3) [12] [14]

Model answer

High-risk conditions accelerate atherosclerosis and need intensified BP/lipid/lifestyle pathways per AHA high-risk paediatric guidance. [4]

Correct serial BP, lifestyle diet/activity/smoke-free, obesity care without stigma if relevant, medication review, coordinated nephrology targets. [1] [4] [5]

Written targets, chase abnormal results, clear specialty follow-up, return precautions if headache/visual change/encephalopathy signs. [12] [14]

References

[1]Flynn JT Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics, 2017.PMID 28827377
[2]US Preventive Services Task Force Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA, 2023.PMID 37462699
[3]Daniels SR Lipid screening and cardiovascular health in childhood. Pediatrics, 2008.PMID 18596007
[4]de Ferranti SD Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association. Circulation, 2019.PMID 30798614
[5]Hampl SE Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics, 2023.PMID 36622115
[6]Wiegman A Lipid Screening, Action, and Follow-up in Children and Adolescents. Current cardiology reports, 2018.PMID 30090990
[7]de Ferranti SD Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians. The Journal of pediatrics, 2017.PMID 28209292
[8]Blanchette E Implications of the 2017 AAP Clinical Practice Guidelines for Management of Hypertension in Children and Adolescents: a Review. Current hypertension reports, 2019.PMID 30953215
[9]Kuo DZ Recognition and Management of Medical Complexity. Pediatrics, 2016.PMID 27940731
[10]Mills E Association between caregiver concern for clinical deterioration and critical illness in children presenting to hospital: a prospective cohort study. The Lancet. Child & adolescent health, 2025.PMID 40451224
[11]Boylen S Impact of professional interpreters on outcomes for hospitalized children from migrant and refugee families with limited English proficiency: a systematic review. JBI evidence synthesis, 2020.PMID 32813387
[12]Starmer AJ Changes in medical errors after implementation of a handoff program. The New England journal of medicine, 2014.PMID 25372088
[13]Katz AL Informed Consent in Decision-Making in Pediatric Practice. Pediatrics, 2016.PMID 27456510
[14]Burvenich R Effectiveness of safety-netting approaches for acutely ill children: a network meta-analysis. The British journal of general practice : the journal of the Royal College of General Practitioners, 2025.PMID 39117428

SAQ 1 (10 marks)

An asymptomatic 9-year-old has office BP 124/78 using an unknown cuff size. BMI is elevated. Father had MI at 44. [1] [3]

Outline your immediate BP assessment steps. (3) [1]

What cardiovascular history and examination details matter most? (3) [1] [3]

How will you approach lipids given guideline controversy? (4) [2] [3]

Model answer

Re-measure after rest with correct cuff size; repeat abnormal readings; stage with paediatric guidance rather than adult cut-offs; plot BMI. [1]

History: premature ASCVD/FH family history, kidney/heart disease, drugs, sleep, diet, activity, smoke/vape. Exam: pulses/femorals, heart, thyroid, acanthosis, oedema. [1] [3]

SAQ 2 (10 marks)

A child with CKD is reviewed in clinic for cardiovascular risk. [4]

Why is average well-child screening intensity inadequate here? (3) [4]

List first-line preventive actions you can start in general paediatrics. (4) [1] [4] [5]

Safety-net and referral principles. (3) [12] [14]

Model answer

High-risk conditions accelerate atherosclerosis and need intensified BP/lipid/lifestyle pathways per AHA high-risk paediatric guidance. [4]

Correct serial BP, lifestyle diet/activity/smoke-free, obesity care without stigma if relevant, medication review, coordinated nephrology targets. [1] [4] [5]

Written targets, chase abnormal results, clear specialty follow-up, return precautions if headache/visual change/encephalopathy signs. [12] [14]

References

[1]Flynn JT Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics, 2017.PMID 28827377
[2]US Preventive Services Task Force Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA, 2023.PMID 37462699
[3]Daniels SR Lipid screening and cardiovascular health in childhood. Pediatrics, 2008.PMID 18596007
[4]de Ferranti SD Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association. Circulation, 2019.PMID 30798614
[5]Hampl SE Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics, 2023.PMID 36622115
[6]Wiegman A Lipid Screening, Action, and Follow-up in Children and Adolescents. Current cardiology reports, 2018.PMID 30090990
[7]de Ferranti SD Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians. The Journal of pediatrics, 2017.PMID 28209292
[8]Blanchette E Implications of the 2017 AAP Clinical Practice Guidelines for Management of Hypertension in Children and Adolescents: a Review. Current hypertension reports, 2019.PMID 30953215
[9]Kuo DZ Recognition and Management of Medical Complexity. Pediatrics, 2016.PMID 27940731
[10]Mills E Association between caregiver concern for clinical deterioration and critical illness in children presenting to hospital: a prospective cohort study. The Lancet. Child & adolescent health, 2025.PMID 40451224
[11]Boylen S Impact of professional interpreters on outcomes for hospitalized children from migrant and refugee families with limited English proficiency: a systematic review. JBI evidence synthesis, 2020.PMID 32813387
[12]Starmer AJ Changes in medical errors after implementation of a handoff program. The New England journal of medicine, 2014.PMID 25372088
[13]Katz AL Informed Consent in Decision-Making in Pediatric Practice. Pediatrics, 2016.PMID 27456510
[14]Burvenich R Effectiveness of safety-netting approaches for acutely ill children: a network meta-analysis. The British journal of general practice : the journal of the Royal College of General Practitioners, 2025.PMID 39117428